CLINSQUARE: CLINICAL RESEARCH COURSES
Wednesday, April 23, 2025
CLINSQUARE: Clinical Rsearch Courses by LIFEPRONOW
Home2020

Yearly Archives: 2020

FDA Clears Phase II COVID-19 Trial of ViralClear’s Merimepodib

admin - 0
May 18, 2020: "BioSig Technologies (“BioSig” or the “Company”) and its majority-owned subsidiary, ViralClear Pharmaceuticals, Inc. (ViralClear), announced that the U.S. FDA has completed...

FDA OK’s for Lynparza for metastatic castration-resistant prostate cancer

admin - 0
May 20, 2020: "AstraZeneca and MSD announced that Lynparza (olaparib) has been approved in the US for patients with homologous recombination repair (HRR) gene-mutated metastatic castration-resistant...

Merk’s Strategic Investments from UPMC Enterprises for Infectious Diseases and Antimicrobial Stewardship

admin - 0
May 19, 2020: "Merck and UPMC announced that Infectious Disease Connect Inc., a UPMC-backed company offering telemedicine-enabled solutions to hospitals for treatment of infectious diseases, has combined...

USDA, FDA Strengthen U.S. Food Supply Chain Protections

admin - 0
May 19, 2020: "As the COVID-19 pandemic response continues, the U.S. Department of Agriculture and the U.S. Food and Drug Administration have been working...

How to Become a Medical Writer in 2020

admin - 0
Medical writing is the making of scientific documents by specialized writers.Generally, a medical writer closely works with scientists, doctors and other subject matter experts...

FDA’s OK for Roche’s Tecentriq for metastatic non-small cell lung cancer

admin - 0
May 19, 2020: "Roche announced that the US FDA has approved Tecentriq® (atezolizumab) as a first-line (initial) treatment for adults with metastatic non-small cell...

Bevespi Aerosphere approved in China for patients with COPD

admin - 0
May 18, 2020: "AstraZeneca’s Bevespi Aerosphere (glycopyrronium/formoterol fumarate)has been approved in China as a maintenance treatment to relieve symptoms in patients with chronic obstructive pulmonary disease...

AZ and Daiichi Sankyo’s third Breakthrough Therapy Designation for Enhertu

admin - 0
May 18, 2020: "AstraZeneca and Daiichi Sankyo Company, Limited (Daiichi Sankyo)’s Enhertu (trastuzumab deruxtecan) has been granted Breakthrough Therapy Designation (BTD) in the US for the...

ViiV HIV prevention trial stopped early on the efficacy

admin - 0
May 18, 2020: "ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders announced the...

NICE COVID-19 rapid guideline for chronic kidney disease

admin - 0
May 15, 2020: The purpose of this guideline is to maximise the safety of adults with chronic kidney disease during the COVID-19 pandemic. It...

AveXis receives EC approval for Zolgensma® for spinal muscular atrophy

admin - 0
May 19, 2020: "AveXis, a Novartis company announced the EC granted conditional approval for Zolgensma® (onasemnogene abeparvovec) for the treatment of patients with 5q spinal...

Novo Nordisk’s wins big obesity ambitions take shape with semaglutide

admin - 0
May 13, 2020: "Novo Nordisk announced headline results from STEP 4, the first completed phase 3a trial in the STEP programme. STEP 4 is...
1...363738...65Page 37 of 65
- Advertisment -

Most Read

EDITOR PICKS

POPULAR POSTS

POPULAR CATEGORY

ABOUT US

LifeProNow provides guidance and high quality contents to help job seekers to get their dream Job. All the contents are written by experienced folks and peer reviewed by experts.

Contact us: [email protected]

FOLLOW US

© LifeProNow | All Rights Reserved